• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红霉素与维吉尼亚霉素在体外对大核糖体亚基结合的竞争。

Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.

作者信息

Parfait R, Di Giambattista M, Cocito C

出版信息

Biochim Biophys Acta. 1981 Jul 27;654(2):236-41. doi: 10.1016/0005-2787(81)90177-5.

DOI:10.1016/0005-2787(81)90177-5
PMID:6793070
Abstract

When the S component of virginiamycin binds in vitro to the 50 S ribosomal subunit, a change of fluorescence intensity proportional to the amount of complex formed occurs. Erythromycin competes with virginiamycin S for attachment to ribosomes, and removes previously bound virginiamycin S from its target, as revealed by spectrofluorimetric analysis. The 50 S subunits which are incubated with the M component of virginiamycin (50 S*) have an increased affinity for virginiamycin S (the association constants of virginiamycin S with ribosomes are 2.5 x 10(6) M-1 in the absence of virginiamycin M, and 15 x 10(6) M-1 in its presence). Erythromycin does not compete with virginiamycin S for attachment to 50 S* subunits nor is it able to remove virginiamycin S previously bound to the 50 S* subunit. Thus, virginiamycin M produces a change in ribosomes, which results in a tighter complex virginiamycin S-50 S* subunit. Such change does not require the presence of virginiamycin M, however, as shown by the observation that ribosomes to which labeled virginiamycin M is transiently linked bind virginiamycin S in a form that cannot be removed by erythromycin.

摘要

当维吉尼亚霉素的S组分在体外与50S核糖体亚基结合时,会发生荧光强度的变化,该变化与形成的复合物的量成正比。红霉素与维吉尼亚霉素S竞争附着于核糖体,并从其靶标上移除先前结合的维吉尼亚霉素S,这通过荧光光谱分析得以揭示。与维吉尼亚霉素M组分(50S*)一起孵育的50S亚基对维吉尼亚霉素S的亲和力增加(在不存在维吉尼亚霉素M时,维吉尼亚霉素S与核糖体的缔合常数为2.5×10⁶M⁻¹,在其存在时为15×10⁶M⁻¹)。红霉素不与维吉尼亚霉素S竞争附着于50S亚基,也无法移除先前结合到50S亚基上的维吉尼亚霉素S。因此,维吉尼亚霉素M会使核糖体发生变化,从而导致维吉尼亚霉素S-50S*亚基形成更紧密的复合物。然而,如观察到与标记的维吉尼亚霉素M短暂连接的核糖体以红霉素无法移除的形式结合维吉尼亚霉素S所示,这种变化并不需要维吉尼亚霉素M的存在。

相似文献

1
Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.红霉素与维吉尼亚霉素在体外对大核糖体亚基结合的竞争。
Biochim Biophys Acta. 1981 Jul 27;654(2):236-41. doi: 10.1016/0005-2787(81)90177-5.
2
Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.弗吉尼亚霉素组分和红霉素与细菌核糖体相互作用的荧光停流分析。
J Biol Chem. 1983 Dec 10;258(23):14233-8.
3
Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.维吉尼亚霉素S与大肠杆菌核糖体结合的特性研究。
Eur J Biochem. 1978 May;86(1):187-91. doi: 10.1111/j.1432-1033.1978.tb12298.x.
4
The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits.维吉尼亚霉素M与细菌核糖体及核糖体亚基的体外结合
Mol Gen Genet. 1978 Oct 25;166(1):53-9. doi: 10.1007/BF00379729.
5
A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.维吉尼亚霉素S与细菌核糖体相互作用的荧光光谱研究。
Mol Gen Genet. 1978 Oct 25;166(1):45-51. doi: 10.1007/BF00379728.
6
Action of ions and pH on the binding of virginiamycin S to ribosomes.离子和pH值对维吉尼亚霉素S与核糖体结合的作用。
Biochim Biophys Acta. 1983 May 4;757(1):92-100. doi: 10.1016/0304-4165(83)90156-3.
7
Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.大环内酯类药物与协同霉素对细菌核糖体的拮抗相互作用。
J Antimicrob Chemother. 1986 Sep;18(3):307-15. doi: 10.1093/jac/18.3.307.
8
Use of 50 S-binding antibiotics to characterize the ribosomal site to which peptidyl-tRNA is bound.使用50 S结合抗生素来表征肽基-tRNA所结合的核糖体位点。
J Biol Chem. 1992 Sep 25;267(27):19117-22.
9
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.与突变的大核糖体亚基结合的MLSBK抗生素结构为耐药性提供了结构上的解释。
Cell. 2005 Apr 22;121(2):257-70. doi: 10.1016/j.cell.2005.02.005.
10
Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.通过荧光能量转移对维吉尼亚霉素S在细菌核糖体上的结合位点进行定位。
Biochemistry. 1986 Jun 17;25(12):3540-7. doi: 10.1021/bi00360a011.

引用本文的文献

1
Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant .替加环素与氨基糖苷类药物联合应用对碳青霉烯类耐药. 的协同杀菌作用的蛋白质组学研究
Front Cell Infect Microbiol. 2022 Jun 30;12:920761. doi: 10.3389/fcimb.2022.920761. eCollection 2022.
2
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.链阳菌素达福普汀和奎奴普汀的协同作用诱导核糖体肽基转移酶中心发生改变。
BMC Biol. 2004 Apr 1;2:4. doi: 10.1186/1741-7007-2-4.
3
Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.
金黄色葡萄球菌中L22核糖体蛋白突变导致对奎奴普丁-达福普汀耐药
Antimicrob Agents Chemother. 2002 Jul;46(7):2200-7. doi: 10.1128/AAC.46.7.2200-2207.2002.
4
Inhibitory action of virginiamycin components on cell-free systems for polypeptide formation from Bacillus subtilis.维吉尼亚霉素组分对枯草芽孢杆菌无细胞多肽合成体系的抑制作用。
Arch Microbiol. 1983 Aug;135(1):8-11. doi: 10.1007/BF00419474.